alexa Botulinum toxin should be first-line treatment for poststroke spasticity
Neurology

Neurology

International Journal of Neurorehabilitation

Author(s): Geoffrey Sheean

Abstract Share this page

Each year, about 100 000 people in the UK suffer their first stroke,1 of which some will die, and many of the survivors will suffer significant impairment.2 Much of the impairment is due to neurological deficits from damage to motor, sensory and language pathways. Some survivors also develop some type of motor overactivity as a result of damage to the upper motor neurons: spasticity is one type and affects up to 38% of patients after stroke.3 Spasticity can result in postural deformity, pain and impaired passive and active movement, and consequently impaired function. Quality of life is reduced,4 and care giver burden is increased.5

Before the advent of botulinum neurotoxin (BoNT) therapy, treatment of spasticity after stroke consisted of physiotherapy measures (stretching, splinting, casting) and oral anti-spasticity agents, such as baclofen

This article was published in J Neurol Neurosurg Psychiatry and referenced in International Journal of Neurorehabilitation

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemic[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords